Publications by authors named "Thomas A Hope"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

10,637

Total Likes

36

Extended Reach

12,314

Social Features

3
M
Motion robust high resolution 3D free-breathing pulmonary MRI using dynamic 3D image self-navigator.
Wenwen Jiang, Frank Ong, Kevin M Johnson, Scott K Nagle, Thomas A Hope, Michael Lustig, Peder E Z Larson

Magn Reson Med· June 2018

Videos about Article: user user

2 1 1

View All Article and Social Media Activity
U
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study.
Madeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, Laya Rahbar Nikoukar, Michael Schäfers, Thomas A Hope

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancer.
William S Chen, Abuzar Moradi Tuchayi, Ali Sabbagh, Inkyu Kim, Evan Porter, Thomas A Hope

JNCI Cancer Spectr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long-term survival.
Kemal Caglar Gogebakan, Zizi Elsisi, Felipe Montano-Campos, Lukas Owens, Yibai Zhao, Thomas A Hope

Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP).
Alicia K Morgans, Alex Chehrazi-Raffle, Tamim Niazi, Neal D Shore, Ashley E Ross, Thomas A Hope

Future Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary: SNMMI/ACNM Procedure Standard for Posttreatment Imaging of Lu-Based Radiopharmaceuticals.
Carlos Uribe, Amir Iravani, Bital Savir-Baruch, Heather Jacene, Stephen A Graves, Thomas A Hope

J Nucl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis.
Ken Herrmann, Jochen Walz, Steven MacLennan, Alberto Briganti, Philip Cornford, Thomas A Hope

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective study.
Lena M Unterrainer, Andrea Farolfi, Tristan Grogan, Masatoshi Hotta, Loïc Djaileb, Thomas A Hope

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4D-MRI at 0.55T for internal target volume delineation in liver radiation therapy planning.
Xin Miao, Pan Su, Michael A Ohliger, Yang Yang, Jianing Pang, Thomas A Hope

Med Phys· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flip Angle Optimization for Hepatobiliary Phase MRI at 0.55 T in Patients With Metastatic Neuroendocrine Tumors: A Prospective Study.
Cheng W Hong, Yang Yang, Isabelle Remick, Pan Su, Pedro Itriago-Leon, Thomas A Hope

AJR Am J Roentgenol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.
Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, R Bryan Rumble, Mary-Ellen Taplin, Thomas A Hope

J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data.
Azadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, Johan Blakkisrud, Sara Kurkowska, Thomas A Hope

J Nucl Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy.
Vishnu Murthy, Vinicius Ludwig, Andrei Gafita, Thomas A Hope, Jeremie Calais

J Nucl Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Funding Reductions Threaten the Future of Medical Innovation.
Johannes Czernin, Carolyn J Anderson, Ramsey Derek Badawi, Henryk Barthel, Frank M Bengel, Thomas A Hope

J Nucl Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre- or post-chemotherapy: effect on PSMA uptake.
Surekha Yadav, Abuzar Moradi Tuchayi, Moein Moradpour, Fei Jiang, Roxanna Juarez, Thomas A Hope

EJNMMI Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkers.
Grace Kong, Geertje Noe, Cherie Chiang, Ken Herrmann, Thomas A Hope

J Neuroendocrinol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Dosimetry, and Feasibility of [Ga]Ga-PSMA-R2 as an Imaging Agent in Patients with Biochemical Recurrence or Metastatic Prostate Cancer.
Liza Lindenberg, Thomas A Hope, Frank I Lin, Steven P Rowe, Darko Pucar

J Nucl Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Added Value of Whole-Body Diffusion-Weighted Imaging in Patients Undergoing Prostate-Specific Membrane Antigen Positron Emission Tomography.
Cheng William Hong, Spencer C Behr, Fei Jiang, Yingbing Wang, Sina Houshmand, Thomas A Hope

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
Silke Gillessen, Fabio Turco, Ian D Davis, Jason A Efstathiou, Karim Fizazi, Thomas A Hope

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers.
Martina Sollini, Jeremie Calais, Arturo Chiti, Louise Emmett, Stefano Fanti, Thomas A Hope

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes.
Ruben Raychaudhuri, Abuzar Moradi Tuchayi, Soon Khai Low, Ali T Arafa, Laura S Graham, Thomas A Hope

Eur Urol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)" [Eur Urol. 86(1) (2024) 52-60].
Wesley R Armstrong, Amar U Kishan, Kiara M Booker, Tristan R Grogan, David Elashoff, Thomas A Hope

Eur Urol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET.
Thomas A Hope, Jeremie Calais, Ajit H Goenka, Uwe Haberkorn, Mark Konijnenberg

J Nucl Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.
Alan H Bryce, Neeraj Agarwal, Himisha Beltran, Maha H Hussain, Oliver Sartor, Thomas A Hope

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study.
Lena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, Tristan Grogan, Honest Ndlovu

J Nucl Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Toxicity of [Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data.
Vishnu Murthy, Andrew F Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, Thomas A Hope

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis